We are live on ! Find out more
TLSIW icon

TriSalus Life Sciences Warrant
TLSIW

23 hedge funds and large institutions have $160K invested in TriSalus Life Sciences Warrant in 2023 Q2 according to their latest regulatory filings, with 2 funds opening new positions, 4 increasing their positions, 2 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

50,200% more call options, than puts

Call options by funds: $1.51M | Put options by funds: $3K

100% more repeat investments, than reductions

Existing positions increased: 4 | Existing positions reduced: 2

4% less funds holding

Funds holding: 24 → 23 (-1)

33% less capital invested

Capital invested by funds: $238K → $160K (-$77.8K)

33% less first-time investments, than exits

New positions opened: 2 | Existing positions closed: 3

Holders
23
Holders Change
-1
Holders Change %
-4.17%
% of All Funds
0.36%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
4
Reduced
2
Closed
3
Calls
$1.51M
Puts
$3K
Net Calls
+$1.51M
Net Calls Change
+$29K

Top Buyers

1
ETH
Exos TFP Holdings
New York
+$10.7K
2
SFA
Sequoia Financial Advisors
Ohio
+$4.22K
3
FTUS
Flow Traders U.S.
New York
+$465
4
HF
HRT Financial
New York
+$7

Top Sellers

1
Balyasny Asset Management
Balyasny Asset Management
Illinois
-$7.59K
2
SCM
Shaolin Capital Management
Florida
-$5.24K
3
FFAM
Forge First Asset Management
Canada
-$3.94K
4
FSI
Flow State Investments
Illinois
-$329
5
Jane Street
Jane Street
New York
-$1
Name Holding Trade Value Shares
Change 		Change in
Stake
MF
1
Magnetar Financial
Illinois
$58.1K – – –
DM
2
Deerfield Management
New York
$14K – – –
PAMP
3
Polar Asset Management Partners
Ontario, Canada
$12K – – –
KL
4
KIM LLC
Kansas
$8.04K – – –
ETH
5
Exos TFP Holdings
New York
$7.02K +$10.7K +158,257 +1,692%
KC
6
Kepos Capital
New York
$7K +$9.85K +145,000 New
RCM
7
Radcliffe Capital Management
Pennsylvania
$6.67K – – –
VI
8
Vestcor Inc
New Brunswick, Canada
$6K – – –
MP
9
MSD Partners
New York
$5.59K – – –
Point72 Asset Management
10
Point72 Asset Management
Connecticut
$5.59K – – –
HCM
11
Highbridge Capital Management
New York
$4.89K – – –
Walleye Capital
12
Walleye Capital
New York
$4.38K – – –
BCL
13
Bracebridge Capital LLC
Massachusetts
$4.14K – – –
SFA
14
Sequoia Financial Advisors
Ohio
$3K +$4.22K +62,187 New
CCM
15
Context Capital Management
California
$3K – – –
AA
16
AQR Arbitrage
Connecticut
$2.79K – – –
CF
17
Cantor Fitzgerald
New York
$2.58K – – –
CM
18
CastleKnight Management
New York
$1.94K – – –
HF
19
HRT Financial
New York
$1K +$7 +110 +0.4%
FTUS
20
Flow Traders U.S.
New York
$1K +$465 +6,850 +66%
Jane Street
21
Jane Street
New York
$833 -$1 -18 -0.1%
Nomura Holdings
22
Nomura Holdings
Japan
$454 – – –
FSI
23
Flow State Investments
Illinois
$426 -$329 -4,838 -32%
CS
24
Clear Street
New York
$4 – +2 +2%
Balyasny Asset Management
25
Balyasny Asset Management
Illinois
– -$7.59K -95,510 Closed
1
2

TLSIW Hedge Fund Activity: Q2 2023 in Review

23 of the 6,369 institutional investors tracked by Wall St. Rank reported a position in TriSalus Life Sciences Warrant (TLSIW) for Q2 2023, worth a combined $160K — down 33% from $238K a quarter earlier.

Sellers outnumbered buyers: 3 funds closed out of TLSIW and 2 opened new positions — a net loss of 1 holder — while 2 trimmed existing stakes and 4 added.

The largest buyer was Exos TFP Holdings, adding an estimated $10.7K. The largest seller was Balyasny Asset Management, exiting entirely with an estimated $7.59K sold.

  • 23 institutional investors held TriSalus Life Sciences Warrant (TLSIW) as of Q2 2023, down from 24 in Q1 2023.
  • Funds reported $160K of TriSalus Life Sciences Warrant stock for Q2 2023, down 33% quarter-over-quarter.
  • 2 funds opened new TriSalus Life Sciences Warrant positions in Q2 2023 and 3 closed out, a net change of -1 holder.
  • The largest TriSalus Life Sciences Warrant buyer in Q2 2023 was Exos TFP Holdings, an estimated $10.7K added.
  • The largest TriSalus Life Sciences Warrant seller in Q2 2023 was Balyasny Asset Management, an estimated $7.59K sold.

Based on aggregated 13F filings for Q2 2023.